About
Joshua Silverman is a U.S. investment professional and public-company director/executive with a background spanning Iroquois Capital Management, Parkfield Funding, and Vertical Ventures. He later moved into operating and board roles across public biotech and health-related companies including PharmaCyte Biotech, Femasys, TNF Pharmaceuticals/MyMD, AYRO/StableX, Synaptogenix, and Petros Pharmaceuticals. Earlier in his career, he worked at Joele Frank and served as assistant press secretary to the President of the United States.
Areas of interest
biotechlife sciencescapital marketspublic-company governancehealthcare investingwomen's healthcorporate restructuringsspecial situations